Evidence map›Paper›PMID 41536830›Full record

ArticleAIMS public health2025

Significant risk of developing asbestos-related diseases in Japan's industries: An analysis of workers' compensation.

Leli Hesti Indriyati, Masamitsu Eitoku, Naw Awn J-P, Taro Tamura, Narufumi Suganuma

Abstract read
In one paragraph

Article in AIMS public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Murine models of pulmonary fibrosis: mechanisms, limitations and translational insights.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leli Hesti IndriyatiDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Masamitsu EitokuDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Naw Awn J-PDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Taro TamuraDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Narufumi SuganumaDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asbestos has been used in various industries, and prolonged exposure can increase the risk of asbestos-related disease (ARD). Although the use of asbestos has been prohibited in Japan since 2012, it was imported well into the 2000s. This study aimed to identify industries in Japan whose workers are at heightened risk of developing ARD. Methods: This study was based on a comprehensive analysis of fiscal year data from the Survey of Claims and Decisions on Benefits for Asbestos-Related Health Damage and calendar year data from the Status of Pneumoconiosis Health Management Implementation in Japan. Occupations associated with asbestos exposure risk were identified using the Japan Standard Industrial Classification (Rev. 14, 2023). The incidence rate ratio (IRR) was estimated using Poisson regression analysis. Results: This study includes 8,971,500 person-years from 2006 to 2022. Construction workers showed the strongest positive associations with all ARDs. Within the manufacturing sector, shipyard workers were particularly vulnerable to ARDs, although a notable exception to this was the positive correlation with asbestosis among workers in the ceramic industry (IRR 1.56; 95% Conclusions: This study suggests that, despite asbestos being banned in Japan for the past 13 years, cases of ARDs continue to occur in various industries, with construction and shipyard workers being at highest risk. Consequently, individuals with prior asbestos exposure require continuous monitoring to avoid potential adverse health consequences.

Indexed as

asbestosasbestos-related disease (ARD)Japanmesotheliomaworkers

Identifiers

PMID41536830
PMCPMC12795769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.